Innovation Teams

Channeling MIT innovation to benefit the world

The Innovation Teams (I-Teams) course brings together students from MIT Sloan and the MIT School of Engineering for a semester-long project, assessing the commercial feasibility of novel MIT technologies. Lectures focus on building the tools and insights necessary for students to perform commercial due diligence on promising early-stage inventions. Student teams are then matched with project ideas that are at the proof-of-concept stage in MIT Laboratories. The I-Teams then apply classroom theory to deliver a full go-to-market analysis as part of their final report and presentation to their project partner’s principal investigator and research team.

The I-Teams Process

Throughout their project, each team has access to faculty, business mentors, practitioners, and other students. Before the midterm, students develop a short presentation outlining the key performance indicators' of the technology and how they compare to competitive alternatives in a range of applications. In the final report, the full go-to-market analysis prepared by the students includes the technology’s two most promising applications with key technical requirements, both market and competitive analyses, and recommendations for the most effective commercialization strategy.

I-Teams Opportunities

The I-Teams course is one of MIT’s signature Action Learning classes. By combining business analysis with technical insights, students deepen their understanding of science commercialization and develop skills that will enable them to effectively approach the commercialization of inventions throughout their careers.

In some cases, students on I-Teams projects continue to work with their project partner’s principal investigator to shape commercialization beyond the conceptual stage. Several student teams have joined with the principal investigator’s and/or other I-Teams students to compete in the MIT $100K Entrepreneurship Competition. Companies created from the I-Teams course have included Lantos Technologies, Myomo (neuro-robotic™ medical devices), and several ongoing “proto startups.”